Charles River Laboratories, a Wilmington, Mass., pharma services giant, is closing a Skokie office that will result in the ...
Charles River has been riding rough waters in 2024, and as the CRO’s CEO predicted, the third quarter proved no exception. | ...
Charles River Laboratories raised its full-year profit forecast after beating analysts' estimates for quarterly results as the contract research firm expects demand to stabilize from biotech clients ...
Races begin this Friday on the Charles River at 7:45 a.m. and run until just before 11 a.m. The regatta continues Saturday and Sunday, with races from 7:45 a.m. until 4 p.m. Click here for the ...
In a report released yesterday, Charles Rhyee from TD Cowen maintained a Hold rating on Charles River Labs (CRL – Research Report), with ...
Have you evaluated the performance of Charles River Laboratories' (CRL) international operations for the quarter ending September 2024? Given the extensive global presence of this medical research ...
The Charles River is ready for the rowers. Starting today, more than 12,000 athletes and tens of thousands of fans will head to Greater Boston’s iconic river for the three-day Head of the ...
In a report released on November 7, Patrick B Donnelly from Citi maintained a Sell rating on Charles River Labs (CRL – Research Report).
Stevens said she is looking beyond the banks of the Charles River. She wants to make it a citywide event and attract residents from neighborhoods that don’t directly touch the river. Spectators ...
Charles River Laboratories International Inc. (CRL) on Wednesday reported third-quarter earnings of $69.7 million. On a per-share ...
With a market cap of $9.4 billion, Wilmington, Massachusetts-based Charles River Laboratories International, Inc. (CRL) is a leading contract research organization (CRO) in the healthcare sector.
The world’s largest three-day annual rowing event drew thousands of people to the banks of the Charles River this weekend to enjoy the crisp fall weather, a welcome change from last year’s ...